This compound is an impurity standard for paricalcitol, a vitamin D analog. It is used as a reference material in pharmaceutical quality control and research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 132015-95-3
1,25-dihydroxycalciferol
pharmaceutical raw material
Dichloro[(S)-(-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl]ruthenium (II)
pharmaceutical intermediate
3,4,5-Trifluorobenzaldehyde
pharmaceutical intermediate
(3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone
pharmaceutical intermediate
(2R,3S)-N-benzoyl-3-phenylisoserine
pharmaceutical intermediate
22Z-Paricalcitol
research compound
Paricalcitol Impurity 8
pharmaceutical intermediate
Paricalcitol
pharmaceutical raw material
trans-(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
BPKAHTKRCLCHEA-AAUJZVBSSA-N
C[C@H](/C=C/[C@@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C